GlassScriptPhysician profile
Louis Arnold
NPI 1447708557
$1,424.76
in general payments reported to CMS, 2019-2025
17 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $369 · 2022: $145 · 2023: $263 · 2024: $526 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $118.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $359.25 | 2023-2024 | Orgovyx |
| Medtronic, INC. | $307.17 | 2022-2025 | Interstim |
| Srs Medical Systems, INC. | $174.84 | 2021 | |
| Astellas Pharma US INC | $164.95 | 2021 | |
| Ferring Pharmaceuticals INC. | $80.73 | 2024 | Adstiladrin |
| 180 Medical, INC. | $59.33 | 2021-2023 | |
| Urovant Sciences INC | $32.96 | 2022 | |
| Merck Sharp & Dohme LLC | $31.61 | 2023 | Lynparza, Keytruda, Welireg |
| Myriad Genetic Laboratories, INC. | $31.49 | 2024 | Prolaris |
| Pfizer INC. | $28.49 | 2024 | |
| Blue Earth Diagnostics | $27.71 | 2023 | |
| Dendreon Pharmaceuticals LLC | $26.42 | 2024 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $26.39 | 2024 | Bard Urinary Drainage Bag |
| Endo Pharmaceuticals INC. | $24.98 | 2023 | Xiaflex, Aveed |
| Sagent Pharmaceuticals | $18.81 | 2024 | Glydo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.28 | 2022 | |
| Aroa Biosurgery Incorporated | $14.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.